Peregrine Pharmaceuticals shares owned by Summit Investment Advisors
Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Summit Investment Advisors
from 13F filings
Historical chart of Summit Investment Advisors investment in Peregrine Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Peregrine Pharmaceuticals held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Peregrine Pharmaceuticals by Summit Investment Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $40k | 6.2k | 6.50 |
2023-09-30 | $58k | 6.2k | 9.44 |
2023-06-30 | $66k | 4.7k | 13.97 |
2023-03-31 | $88k | 4.7k | 18.76 |
2022-12-31 | $81k | 4.7k | 17.23 |
2022-09-30 | $89k | 4.7k | 18.96 |
2022-06-30 | $71k | 4.7k | 15.12 |
2022-03-31 | $96k | 4.7k | 20.45 |
2021-12-31 | $137k | 4.7k | 29.18 |
2021-09-30 | $101k | 4.7k | 21.51 |
2021-06-30 | $120k | 4.7k | 25.56 |
2021-03-31 | $86k | 4.7k | 18.32 |
2020-12-31 | $54k | 4.7k | 11.50 |
2020-09-30 | $36k | 4.7k | 7.67 |
2020-06-30 | $31k | 4.7k | 6.60 |
2020-03-31 | $24k | 4.7k | 5.11 |
2019-12-31 | $36k | 4.7k | 7.67 |
2019-09-30 | $25k | 4.7k | 5.32 |
2019-06-30 | $26k | 4.7k | 5.54 |
2019-03-31 | $20k | 4.7k | 4.26 |
2018-12-31 | $19k | 4.7k | 4.05 |
2018-09-30 | $32k | 4.7k | 6.82 |
2018-06-30 | $18k | 4.7k | 3.83 |
More positions owned by Summit Investment Advisors
View all positions for Summit Investment Advisors